^
    CANCER:

    Nasopharyngeal Carcinoma





    Show legend
    Group by Gene:
    Include preclinical:

    PD1 inhibitor
    camrelizumab
    pembrolizumab
    toripalimab-tpzi
    		0
    PD1 inhibitor
    tislelizumab
    nivolumab
    PDR001
    zimberelimab
    penpulimab
    sintilimab
    nedaplatin
    		1
    DNA synthesis inhibitor
    cisplatin
    gemcitabine
    cisplatin + gemcitabine
    2
    Thymidylate synthase inhibitor
    5-fluorouracil
    capecitabine
    3
    Tubulin polymerization promoter, DNA synthesis inhibitor
    carboplatin + gemcitabine
    4
    Tubulin polymerization promoter, Bcl2 inhibitor
    paclitaxel
    carboplatin + paclitaxel
    5
    EGFR inhibitor
    cetuximab
    6
    Topoisomerase I inhibitor
    irinotecan
    7
    Tubulin polymerization inhibitor
    vinorelbine tartrate
    8
    Bifunctional alkylating agent
    ifosfamide
    9
    Topoisomerase II inhibitor
    doxorubicin hydrochloride
    10
    DNA synthesis inhibitor, DNA cross linking agent
    oxaliplatin
    11
    THF dehydrogenase inhibitor, Dihydrofolic acid reductase inhibitor
    methotrexate
    12
    Tubulin polymerization promoter
    carboplatin
    13
    T-cell stimulant
    BRG01
    14
    Microtubule inhibitor, EGFR-targeted antibody-drug conjugate
    MRG003
    15
    VEGFR-2 inhibitor, PD1 inhibitor
    camrelizumab + rivoceranib
    16
    PD1 inhibitor, CCR4 receptor antagonist
    pembrolizumab + FLX475
    17
    PD1 inhibitor, CTLA4 inhibitor
    cadonilimab
    18
    CCR4 receptor antagonist
    FLX475
    DP
    		19
    Chemotherapy
    TPF
    GC
    20
    Immunotherapy
    Immunotherapy
    21
    Topoisomerase II inhibitor, Tubulin polymerization promoter, DNA synthesis inhibitor, Bcl2 inhibitor
    cisplatin + paclitaxel + epirubicin
    22
    DNA synthesis inhibitor, Thymidylate synthase inhibitor
    cisplatin + 5-fluorouracil
    23
    Microtubule stabilizer, Tubulin polymerization promoter
    docetaxel
    24
    Tubulin polymerization promoter, DNA synthesis inhibitor, Bcl2 inhibitor
    cisplatin + paclitaxel
    25
    Microtubule stabilizer, Tubulin polymerization promoter, DNA synthesis inhibitor
    cisplatin + docetaxel
    26
    Microtubule stabilizer, Tubulin polymerization promoter, Thymidylate synthase inhibitor
    carboplatin + docetaxel + 5-fluorouracil
    No biomarker
    PD-L1 expression
    PD-L1 overexpression
    CCR4 overexpression
    EGFR expression
    EGFR positive
    G6PD deletion
    HAVCR2 expression
    LAG3 expression
    IFNG expression
    KDR overexpression
    TMB-H
    SATB1 overexpression
    Chr amplification(11)(q13)
    RARS1-MAD1L1 fusion
    ETV6 amplification
    KLF4 overexpression